Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approved Eywa Pharma Inc's supplemental application for hydrocodone bitartrate and acetaminophen (hydrocodone/acetaminophen) under ANDA 210211.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Hydrocodone bitartrate and acetaminophen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)